A Novel PMVK Variant Associated with Familial Porokeratosis

Area of Science:

• Genetics
• Dermatology
• Biochemistry

Background:

• Porokeratosis is a rare, progressive skin disorder potentially linked to the mevalonate pathway.
• Alterations in key enzymes like phosphomevalonate kinase (PMVK) may disrupt this pathway, contributing to porokeratosis development.

Discussion:

• This study identified a novel heterozygous missense variant (c.207G>T, p. Lys69Asn) in the PMVK gene within a Chinese family affected by porokeratosis.
• The identified variant was absent in healthy family members and 100 unrelated controls, suggesting its causative role.
• In silico analysis predicted the variant to be pathogenic, altering protein structure, including alpha-helix length and hydrogen bonding patterns.

Key Insights:

• A novel pathogenic PMVK gene variant (c.207G>T, p. Lys69Asn) is confirmed as the causative factor for porokeratosis in the studied Chinese family.
• The variant's absence in control populations underscores its specificity to the disease.
• The findings provide critical evidence for the genetic etiology of porokeratosis.

Outlook:

• Further research into the PMVK gene and mevalonate pathway could reveal new therapeutic targets for porokeratosis.
• Investigating the population frequency of this specific PMVK variant in diverse ethnic groups is warranted.
• Understanding the precise molecular mechanisms by which PMVK variants lead to porokeratosis is crucial for developing targeted treatments.